Prognostic significance of low hepatic fat content in advanced chronic liver disease: MRI-PDFF insights

• Published in: Annals of hepatology Vol. 29; no. 4; p. 101507
• Main Authors: Nakamura, Atsushi, Yoshimura, Tsubasa, Ichikawa, Takeshi, Okuyama, Keiji
• Format: Journal Article
• Language: English
• Published: Mexico Elsevier España, S.L.U 01.07.2024; Elsevier
• Subjects: Advanced chronic liver disease; Albumin-bilirubin score; Low hepatic fat; Prognostic factor; Proton density fat fraction; ACLD; MRI; LS; HCC; SLD; LHF; ALBI; MASLD; NASH; PDFF; MELD; Proton density fat fraction; Prognostic factor; Advanced chronic liver disease; ALD; CLD; Low hepatic fat; Albumin-bilirubin score; BMI
• ISSN: 1665-2681; 2659-5982
• DOI: 10.1016/j.aohep.2024.101507

The mechanisms of hepatic fat loss in late-stage metabolic dysfunction-associated fatty liver disease (MASLD) are enigmatic and the prognostic significance of low hepatic fat content (LHF) in chronic liver disease (CLD) is unknown. Proton density fat fraction (PDFF), measured by magnetic resonance imaging (MRI), is considered the most accurate noninvasive method for quantifying hepatic fat content. This study aimed to address these issues by evaluating PDFF. This is a single-center, retrospective study involving 762 patients with CLD, measuring liver stiffness (LS) using MR elastography and PDFF using MRI. LHF was defined as a PDFF ≤ 2.7 % and hepatic reserve function was assessed using the albumin-bilirubin (ALBI) score. Multivariate analysis explored associations between variables. LHF was 27 % in the entire cohort, and PDFF was significantly decreased with LS ≥ 5.5 kPa (p < 0.05). On the multivariate analysis, low body mass index and ALBI score were independently associated with LHF (p < 0.05). In advanced CLD (n = 288), ALBI score and PDFF showed a significant negative correlation regardless of etiology (MASLD/non-MASLD: r= -0.613/-0.233), and the prevalence of LHF increased with progression of ALBI grade (p < 0.01 each). In addition, lower PDFF was associated with increased liver-related and all-cause mortality (p < 0.01), and Cox proportional hazards models extracted LHF as an independent prognostic factor, along with ALBI score and hepatocellular carcinoma (p < 0.05 each). In ACLD, hepatic reserve dysfunction contributed to hepatic fat loss independent of nutritional status, suggesting that LHF may be a poor prognostic factor in all etiologies.